Keywords
Last Name
Institution

Osvaldo Martinez

Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hatton O, Lambert SL, Phillips LK, Vaysberg M, Natkunam Y, Esquivel CO, Krams SM, Martinez OM. Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. Am J Transplant. 2013 Apr; 13(4):883-90.
      View in: PubMed
    2. Martinez O, Johnson JC, Honko A, Yen B, Shabman RS, Hensley LE, Olinger GG, Basler CF. Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol. 2013 Apr; 87(7):3801-14.
      View in: PubMed
    3. Martinez O, Ndungo E, Tantral L, Miller EH, Leung LW, Chandran K, Basler CF. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. J Virol. 2013 Mar; 87(6):3324-34.
      View in: PubMed
    4. Tsibane T, Ekiert DC, Krause JC, Martinez O, Crowe JE, Wilson IA, Basler CF. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog. 2012; 8(12):e1003067.
      View in: PubMed
    5. Martinez O, Leung LW, Basler CF. The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge. Antiviral Res. 2012 Mar; 93(3):416-28.
      View in: PubMed
    6. Leung LW, Martinez O, Reynard O, Volchkov VE, Basler CF. Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry. J Infect Dis. 2011 Nov; 204 Suppl 3:S973-7.
      View in: PubMed
    7. Martinez O, Tantral L, Mulherkar N, Chandran K, Basler CF. Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles. J Infect Dis. 2011 Nov; 204 Suppl 3:S825-32.
      View in: PubMed
    8. Leung LW, Park MS, Martinez O, Valmas C, López CB, Basler CF. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunol Cell Biol. 2011 Oct; 89(7):792-802.
      View in: PubMed
    9. Valmas C, Grosch MN, Schümann M, Olejnik J, Martinez O, Best SM, Krähling V, Basler CF, Mühlberger E. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog. 2010 Jan; 6(1):e1000721.
      View in: PubMed
    10. Bhattacharya P, Grimme S, Ganesh B, Gopisetty A, Sheng JR, Martinez O, Jayarama S, Artinger M, Meriggioli M, Prabhakar BS. Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection. J Virol. 2010 Jan; 84(1):361-71.
      View in: PubMed
    11. Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, Hensley LE, Basler CF. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol. 2010 Feb; 12(2):148-57.
      View in: PubMed
    12. Vaysberg M, Lambert SL, Krams SM, Martinez OM. Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma. Am J Transplant. 2009 Oct; 9(10):2292-302.
      View in: PubMed
    13. Martinez O, Tsibane T, Basler CF. Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery. Int Rev Immunol. 2009; 28(1):69-92.
      View in: PubMed
    14. Vigil A, Martinez O, Chua MA, García-Sastre A. Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther. 2008 Nov; 16(11):1883-90.
      View in: PubMed
    15. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, Crowe JE. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008 Sep 25; 455(7212):532-6.
      View in: PubMed
    16. Reid SP, Valmas C, Martinez O, Sanchez FM, Basler CF. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J Virol. 2007 Dec; 81(24):13469-77.
      View in: PubMed
    17. Vigil A, Park MS, Martinez O, Chua MA, Xiao S, Cros JF, Martínez-Sobrido L, Woo SL, García-Sastre A. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res. 2007 Sep 1; 67(17):8285-92.
      View in: PubMed
    18. Martinez O, Valmas C, Basler CF. Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain. Virology. 2007 Aug 1; 364(2):342-54.
      View in: PubMed
    19. Coughlin M, Lou G, Martinez O, Masterman SK, Olsen OA, Moksa AA, Farzan M, Babcook JS, Prabhakar BS. Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse. Virology. 2007 Apr 25; 361(1):93-102.
      View in: PubMed
    20. Martinez O, Gangi E, Mordi D, Gupta S, Dorevitch S, Lefranc MP, Prabhakar BS. Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses. Endocrinology. 2007 Feb; 148(2):752-61.
      View in: PubMed
    21. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, Carbonnelle C, Volchkov VE, Nichol ST, Basler CF. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol. 2006 Jun; 80(11):5156-67.
      View in: PubMed
    22. Snow AL, Vaysberg M, Krams SM, Martinez OM. EBV B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis. Am J Transplant. 2006 May; 6(5 Pt 1):976-85.
      View in: PubMed
    23. Martinez O, Brackenridge S, El-Idrissi Mel-A, Prabhakar BS. DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells. Int Immunol. 2005 Jun; 17(6):769-78.
      View in: PubMed
    24. Gangi E, Kapatral V, El-Azami El-Idrissi M, Martinez O, Prabhakar BS. Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor. Autoimmunity. 2004 Sep-Nov; 37(6-7):515-20.
      View in: PubMed
    25. Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Oncogene. 2004 Aug 12; 23(36):6083-94.
      View in: PubMed
    26. Efimova EV, Al-Zoubi AM, Martinez O, Kaithamana S, Lu S, Arima T, Prabhakar BS. IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs. Oncogene. 2004 Feb 5; 23(5):1076-87.
      View in: PubMed
    27. Efimova E, Martinez O, Lokshin A, Arima T, Prabhakar BS. IG20, a MADD splice variant, increases cell susceptibility to gamma-irradiation and induces soluble mediators that suppress tumor cell growth. Cancer Res. 2003 Dec 15; 63(24):8768-76.
      View in: PubMed
    28. Martinez OM, Krams SM. Involvement of Fas-Fas ligand interactions in graft rejection. Int Rev Immunol. 1999; 18(5-6):527-46.
      View in: PubMed
    29. Hayashi M, Martinez OM, Krams SM, Burns W, Esquivel CO. Characterization of allograft rejection in an experimental model of small intestinal transplantation. J Gastrointest Surg. 1998 Jul-Aug; 2(4):325-32.
      View in: PubMed
    30. Martinez OM, Villanueva J, Abtahi S, Beatty PR, Esquivel CO, Krams SM. CD30 expression identifies a functional alloreactive human T-lymphocyte subset. Transplantation. 1998 May 15; 65(9):1240-7.
      View in: PubMed
    31. Hayashi M, Martinez OM, Krams SM, Burns W, Esquivel CO. Cytokines are involved in the rejection of small intestine allografts. Transplant Proc. 1997 May; 29(3):1802.
      View in: PubMed
    32. Egawa H, Martinez OM, Quinn MB, Villanueva JC, So S, Esquivel CO, Krams SM. Long-term nonresponsiveness to a liver allograft may be cytokine mediated. Transplant Proc. 1995 Feb; 27(1):241-2.
      View in: PubMed
    33. Egawa H, Martinez OM, Quinn MB, So S, Esquivel CO, Krams SM. Characterization of cytokine expression in an animal model of acute liver allograft rejection. Transplant Proc. 1995 Feb; 27(1):505-6.
      View in: PubMed
    34. Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, Lake J, Roberts JP, Ascher NL. Intragraft cytokine profile during human liver allograft rejection. Transplantation. 1992 Feb; 53(2):449-56.
      View in: PubMed
    Martinez's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067